Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
10/2002
10/03/2002US20020142451 Generation of nodulation inoculant; obtain nutrient broth, mix with iron, monitor cell density factor, evaluate nodulation in propagating plants
10/03/2002US20020142449 Compositions and methods useful for HCV infection
10/03/2002US20020142448 Antibody for use in the diagnosis, treatment and prevention of bone disorders and cancer
10/03/2002US20020142447 DNA encoding the human serine protease EOS
10/03/2002US20020142446 DNA encoding the human serine protease EOS
10/03/2002US20020142440 Peptide for use in the diagnosis and treatment of inflammation, cancer, arteriosclerosis and degenerative disorders
10/03/2002US20020142432 Human endosulfine gene
10/03/2002US20020142429 Elongation factor-2 kinase (EF-2 kinase) and methods of use therefor
10/03/2002US20020142426 33945, a human glycosyltransferase family member and uses therefor
10/03/2002US20020142424 Protein for use as a bioluminescent signaling tool
10/03/2002US20020142420 Cloned leptospira outer membrane protein
10/03/2002US20020142418 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof
10/03/2002US20020142414 Nucleotide sequences coding polypeptide for use in the treatment of lung defects, septic shock or inflammation
10/03/2002US20020142411 Enzymatic deposition and alteration of metals
10/03/2002US20020142400 Production of polyketides in bacteria and yeast
10/03/2002US20020142398 Chemokine expressed in fetal spleen, its production and uses
10/03/2002US20020142392 Human melanocyte stimulating hormone receptor polypeptide and DNA
10/03/2002US20020142389 Soluble T cell receptor
10/03/2002US20020142387 Methods for producing protein domains and analyzing three dimensional structures of proteins by using said domains
10/03/2002US20020142380 Polypeptide for use in the treatment of stroke, retinopathy, reperfusion injuries, cachexia, immunological, nervous system, liver, bone, viral disorders
10/03/2002US20020142379 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
10/03/2002US20020142378 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
10/03/2002US20020142375 Nucleotide sequences coding G protein coupled receptors for use in the diagnosis and treatment of cancer, adult respiratory distress, nervous system disorders and arthritis
10/03/2002US20020142371 Detecting target polynucleotides in a test sample; obtain sample, incubate with probe, detect signal, presence of signal indicates target sequences
10/03/2002US20020142367 Two- dimensional MR spectroscopy techniques
10/03/2002US20020142361 Detection of target biopolymers in sample; obtain sample of target biopolymers, incubate with competitive binding agent, detect signal from bound target
10/03/2002US20020142360 Measuring ceruloplasmin concentration in a blood; obtain sample, incubate with reaction mixture generated in kit, use absorption spectra to determine concentration of ceruoplasmin
10/03/2002US20020142357 TNF receptor action modulation
10/03/2002US20020142356 Immunoassay for C-reactive protein
10/03/2002US20020142354 Determination of protein concentration of mixture; obtain solid support, incubate with protien sample, detect and quantify protein in sample
10/03/2002US20020142351 Peptide or protein microassay method and apparatus
10/03/2002US20020142350 Viral nucleotide sequences for use in the prevention and treatment of viral diseases
10/03/2002US20020142348 Protein-protein interactions and methods for identifying interacting proteins and the amino acid sequence at the site of interaction
10/03/2002US20020142347 Biosensor
10/03/2002US20020142346 Binding compounds and methods for identifying binding compounds
10/03/2002US20020142345 Methods for encoding and decoding complex mixtures in arrayed assays
10/03/2002US20020142344 Targeted molecular bar codes and methods for using the same
10/03/2002US20020142343 Preparing substrate for detecting preferential particle in sample; obtain sample, expose to elution buffer, detect preferential particle by desorption spectrometry, incubate with substrate, recover preferential particle
10/03/2002US20020142342 Nucleic acid analysis using non-templated nucleotide addition
10/03/2002US20020142335 Method of screening for specific binding interactions
10/03/2002US20020142334 Detecting preferential enzymatic activity; generate solid support, incubate with nicotinamide adenine dinucleotide, expose to enzyme, detect and marker complexes and quantify enzyme activity
10/03/2002US20020142332 Monitoring concentration of preferential nucleotide sequences; obtain sample containing nucleotide sequences, incubate with modulator, release nucleotides generated in fluid, measure radioactiviy in sample
10/03/2002US20020142330 Novel glutamate receptor modulatory proteins and nucleic acid molecules and uses therefor
10/03/2002US20020142327 Expression analysis of smarc nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
10/03/2002US20020142326 Screening sample for preferential microorganisms; obtain sample, inubate with probes, detect hybridization, classify microorganisms
10/03/2002US20020142325 PAK 2: modulators of lymphocyte activation
10/03/2002US20020142323 Method and apparatus for detecting enzymatic activity using molecules that change electrophoretic mobility
10/03/2002US20020142322 Method for evaluating the intensity of muscular proteolysis
10/03/2002US20020142320 Diagnosing prostate cancer in humans; obtain fluid or tissue sample from prostate gland, monitor pax gene expression, amplified expression indicates prostate cancer
10/03/2002US20020142317 Methods for the early diagnosis of ovarian cancer
10/03/2002US20020142316 Mutants of the factor VII-activating protease and detection methods using specific antibodies
10/03/2002US20020142314 Complexity management and analysis of genomic data
10/03/2002US20020142309 Nucleic acid hairpin probes and uses thereof
10/03/2002US20020142296 Screening and use of reagents which block or activate intein splicing utilizing natural or homologous exteins
10/03/2002US20020142291 Positive detection lateral-flow apparatus and method for small and large analytes
10/03/2002US20020142289 Analyzing concentration of preferential particles in sample; obtain sample, incubate with ligand, compare to control, determine concentration of preferential particles
10/03/2002US20020142288 Auto-sampler for treatment or pretreatment of sample multicellular organisms for a large particle sorting flow cytometer
10/03/2002US20020142286 Ejecting cells from fluid; obtain fluid which contains cells, expose fluid to focus energy projection, recover cells ejected from fluid
10/03/2002US20020142283 Inhibitors of C-reactive protein induced inflammation
10/03/2002US20020142282 Immortalized human keratinocyte cell line
10/03/2002US20020142280 Decreasing apolipoproteins concentration in humans; obtain human, administer modulator, monitor reduction in apolipoproteins
10/03/2002US20020142173 Novel attachment chemistry for organic molecules to silicon
10/03/2002US20020142004 Immunoreactive and immunotherapeutic molecules
10/03/2002US20020141998 Multi-partite ligands and methods of identifying and using same
10/03/2002US20020141992 Deactivation of collagen receptors
10/03/2002US20020141991 Methods of treating inflammatory disease using antibodies which bind GPR-9-6
10/03/2002US20020141941 PSCA: prostate stem cell antigen and uses thereof
10/03/2002US20020141904 Collection assembly
10/03/2002US20020141902 Flow cytometer
10/03/2002US20020141901 Use of an array of polymeric sensors of varying thickness for detecting analytes in fluids
10/03/2002US20020141625 Apparatus and method for imaging small objects in a flow stream using optical tomography
10/03/2002US20020140933 Method and apparatus for inspecting DNA and method for detecting fluorescence
10/03/2002US20020140925 Method and device for predicting the flocculation threshold of asphaltenes contained in hydrocarbon mixtures
10/03/2002US20020140564 Contact potential difference sensor to monitor oil properties
10/03/2002US20020139752 Efficiently separates liquid and gas phases in flow stream upstream of collection vessel without additional pressure schemes or solvent extractions imposed on flowstream
10/03/2002US20020139751 For affinity capture of biomolecules to meet needs for life sciences such as proteomics and drug discovery
10/03/2002US20020139692 Biosensor system which quantitates the concentration of glucose, cholesterol, etc in blood by measuring electric current
10/03/2002US20020139671 Gas sensor and method of heating the same
10/03/2002US20020139176 Method and apparatus for evanuating retention time of foam beer
10/03/2002US20020139172 Device for analysing preferably animal manure
10/03/2002US20020139170 Smell test device
10/03/2002US20020139012 Methods for identifying modulators of N-type ion channel inactivation
10/03/2002CA2664797A1 Cytotoxic factors for modulating cell death
10/03/2002CA2504413A1 Methods and apparatus for gel-free qualitative and quantitative proteome analysis, and uses therefore
10/03/2002CA2444186A1 Nucleic acid reactions using labels with different redox potentials
10/03/2002CA2443676A1 A novel modulator of non-genomic activity of nuclear receptors (mnar) and uses thereof
10/03/2002CA2442797A1 Human secreted proteins
10/03/2002CA2442777A1 Human secreted proteins
10/03/2002CA2442647A1 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding these human drug-metabolizing proteins, and uses thereof
10/03/2002CA2442581A1 Efficient methods for isolating functional g-protein coupled receptors and identifying active effectors and efficient methods to isolate proteins involved in olfaction and efficient methods to isolate and identifying active effectors
10/03/2002CA2442232A1 Methods and nucleic acids for the analysis of hematopoietic cell proliferative disorders
10/03/2002CA2442089A1 Nucleic acid molecules encoding a transmembran serine protease 9, the encoded polypeptides and methods based thereon
10/03/2002CA2442003A1 Methods for treating neurodegenerative diseases including alzheimer's
10/03/2002CA2441986A1 Methods and products related to fgf dimerization
10/03/2002CA2441985A1 No synthase assay particles and method
10/03/2002CA2441947A1 Human papilloma virus immunoreactive peptides
10/03/2002CA2441926A1 (oxo-pyrazolo[1,5a]pyrimidin-2-yl)alkyl-carboxamides
10/03/2002CA2441763A1 Prognostic methods for breast cancer
10/03/2002CA2441721A1 Human potassium channel
10/03/2002CA2441708A1 Mch1r deficient mice
1 ... 2738 2739 2740 2741 2742 2743 2744 2745 2746 2747 2748 2749 2750 2751 2752 2753 2754 2755 2756 2757 2758 ... 3937